What Chris Thompson has said about Gene therapy
2 quotes · 1 episode · Sep 21, 2026
Chris Thompson, Professor of medicine at Harvard Medical School and chief of interventional gastroenterology at Mass General Brigham, has been quoted on Gene therapy 2 times in 1 episode of Huberman Lab, most recently on September 21, 2026. Each quote below is verbatim and links to the moment it was said.
In their words
Thompson describes a gene therapy that makes pancreatic beta cells co-secrete GLP-1 with insulin in a nutrient-responsive way, delivered by endoscopic ultrasound.
“So basically, when a patient would secrete insulin in a nutrient-responsive way, they'd simultaneously be secreting GLP-1”
Huberman Lab: Best Tools for Gut Health & Weight Loss | Dr. Chris Thompson (Sep 21, 2026) · Listen from 2:17:49
Thompson says the GLP-1 gene therapy has entered clinical trials, possibly in the Netherlands, and could become a one-time treatment.
“They actually just entered clinical trials in, I think, the Netherlands. So it's very exciting. So we'll see how that goes”
Huberman Lab: Best Tools for Gut Health & Weight Loss | Dr. Chris Thompson (Sep 21, 2026) · Listen from 2:20:48
Episodes
Best Tools for Gut Health & Weight Loss | Dr. Chris ThompsonHuberman Lab · Sep 21, 2026 · 2 h 28 min
Andrew Huberman and gastroenterologist Chris Thompson discuss gut anatomy, fiber and the microbiome, GLP-1 drugs, early metabolic testing, gut permeability, and endoscopic and gene-therapy obesity treatments.
Chris Thompson on other topics
- GLP-1 receptor agonists · 3 quotes
- Body weight set point · 2 quotes
- Artificial intelligence in surgery · 2 quotes
- Continuous glucose monitoring · 2 quotes
- Ghrelin · 1 quote
- Intestinal permeability · 1 quote
- Bariatric surgery · 1 quote
- Insulin resistance and metabolic syndrome · 1 quote